Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albicans/glabrata in Switzerland and provide the microbiological and clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Coste, A. T., Kritikos, A., Li, J., Khanna, N., Goldenberger, D., Garzoni, C., Zehnder, C., Boggian, K., Neofytos, D., Riat, A., Bachmann, D., Sanglard, D., Lamoth, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518979/
https://www.ncbi.nlm.nih.gov/pubmed/32661647
http://dx.doi.org/10.1007/s15010-020-01475-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518979/
https://www.ncbi.nlm.nih.gov/pubmed/32661647
http://dx.doi.org/10.1007/s15010-020-01475-8

Ejemplares similares